Highlights bioMérieux

Equities

Real-time Euronext Paris Other stock markets 14:26:43 24/06/2024 BST			5-day change	1st Jan Change
90.85 ^EUR	+2.25%		+0.06%	-9.69%

06-21	BioMérieux Gets US FDA Clearance for Antimicrobial Susceptibility Testing System	MT
06-21	BioMérieux: FDA clearance for Vitek Reveal	CF

Ex-dividend day for final dividend	06-06	FA
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	05-23	MT
BioMérieux S.A. acquired assets from Ares Genetics GmbH.	04-28	CI
BIOMÉRIEUX : Berenberg raises its target	04-26	CF
BIOMÉRIEUX : Stifel raises target price	04-10	CF
BIOMÉRIEUX : Oddo BHF raises its target price	04-10	CF
BIOMÉRIEUX : Invest Securities raises its target	04-10	CF
BIOMERIEUX : A strong start to 2024	04-09
BioMérieux: hailed for its business review and targets	04-09	CF
BioMérieux: targets set for 2024-28	04-09	CF
BioMérieux: growth of over 6% in Q1	04-09	CF
BioMérieux: food safety initiative	04-05	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	03-14
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
BioMérieux: RNPG down 21% in 2023	03-14	CF
BioMérieux Buys Remaining 84% Stake in Canada's Lumed	01-08	MT
BioMérieux: full acquisition of Lumed	01-08	CF
BioMérieux S.A. acquired remaining 84% stake in Luméd inc.	01-04	CI
BIOMÉRIEUX : Invest Securities remains Buy after sales figures	27/10/23	CF
BioMérieux: confirms targets for fiscal 2023	26/10/23	CF

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 03:38 pm